Volume 30, Issue 140 (May & June 2022)                   J Adv Med Biomed Res 2022, 30(140): 269-274 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Talebi S S, Chaman R, Mahdavi S, Enayatrad M, Garkaz O, Khosravi A, et al . Clinical Presentations of Suspected and Confirmed COVID-19 Cases in Shahroud, Iran. J Adv Med Biomed Res 2022; 30 (140) :269-274
URL: http://journal.zums.ac.ir/article-1-6498-en.html
1- Dept. of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran
2- Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
3- Clinical Research Development Unit, Bahar Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
4- Ophthalmic Epidemiology Research Center, Shahroud University of Medical Sciences, Shahroud, Iran
5- Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran
6- Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
7- Dept. of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran , rohani_marzieh@yahoo.com
Full-Text [PDF 333 kb]   (41508 Downloads)     |   Abstract (HTML)  (83816 Views)

 These results necessitate further lines of research into different symptoms and risk factors to help identify COVID-19 cases earlier and start faster treatment.


Full-Text:   (1282 Views)
Introduction
 

According to the World Health Organization, COVID-19 is a serious disease and a global health crisis (1). The rate of virus transmission from a carrier to other people and the mortality rate compared to the flu are  higher and about 2.3% (2) and 3.7%, respectively (3).
Individuals affected by the disease display a wide variety of symptoms including respiratory and gastrointestinal problems, fever and chills, muscle fatigue and pain, and loss of appetite. The disease can cause respiratory distress or kidney damage (4), but fever (98%), cough (76%), shortness of breath (55%), and muscular pain and fatigue (44%), and decreased renal function were found as the most common clinical symptoms of this infection, respectively (5-9). Unlike  the cases with typical coronavirus infections, upper respiratory tract symptoms such as odynophagia, rhinorrhea, and gastrointestinal symptoms such as diarrhea have been reported less frequently in COVID-19 cases (5, 6, 10, 11).
Everyone in the community is exposed to this infection. Men, the elderly, and people with a history of heart disease, hypertension, and diabetes are more likely to develop the disease and die compared to other groups (12). Besides, the current data suggest that children and people under 20 years are less likely to develop the infection. Most infected children have mild or no symptoms (13).
Although the main manifestations of this disease are described in previous studies, due to changes in individual and social characteristics, recognizing clinical differences leads to better diagnosis and treatment. Therefore, this study investigates the demographic and clinical characteristics of COVID-19 cases admitted to Shahroud hospitals and medical centers.


 

Materials and Methods

Following the occurrence of COVID-19 in the early March 2020 in Shahroud, the Vice-Chancellor for Research and Technology of Shahroud University of Medical Sciences designed a project to register systematically and electronically all suspected cases of COVID-19 and trace the contact cases. The health workers recorded the information of all the suspects and the symptoms of people in contact with confirmed cases and followed them up for any symptom development. An electronic medical record was created for all suspected cases. The information collected in this study included demographic information such as age, sex, height and weight, place of residence, occupation, symptoms, and comorbidities. A reverse transcription polymerase chain reaction (RT-PCR) test was performed for all suspected cases in Shahroud. A confirmed case is a person with a positive RT-PCR test. In this study, demographic and clinical variables for the suspected cases were analyzed in both positive and negative RT-PCR groups. The variables examined in this study were age, sex, occupation, years of education, obesity as body mass index(BMI) over 30, signs and symptoms, and comorbidities such as heart disease(HD), diabetes, respiratory disease, and liver and kidney diseases.
We divided the age groups into two categories of under 60 and over 60 years.
Independent samples t-test was run to compare the means of the quantitative variables and the chi-square or Fisher exact tests were used for comparing the qualitative variables among the positive and negative RT-PCR groups. Logistic regression analysis was fitted to compute the odds ratio (OR) and confidence interval of OR for the measured variables. A p-value less than 0.05 was considered statistically significant. SPSS 16 statistical software was used for data analysis.

 

 
Results

The mean age of 3945 suspected cases was 47.81 years, ranging from 18 days to 98 years. The mean year of education was 9.01 years. Besides, 1751 patients (56.1%) were male, 204 (6.5%) were medical staff, and 9 (0.3%) were pregnant women. The most common symptoms were dry cough (38.1%), dyspnea (34%), and fever (31.8%), and the rare symptoms were convulsions, epistaxis, and loss of consciousness. (Table1).


Table 1. Demographic and clinical characteristics of registered cases

P-value Non-patients (2359) N (%) Patients (760)* N (%)  
<0.001 46.41±19.74 52.16±18.99 Age (Mean(SD))
<0.001 9.24±5.71 8.28±5.95 Education in year (Mean(SD))
<0.001 25.62±4.88 26.73±5.21 BMI (Mean(SD))
0.069 1346(57.1) 405(53.3) Sex (Male)
0.510 46(1.9) 12(1.6) Cancer History
<0.001 285(12.1) 134(17.6) Diabetes
0.642 469(19.9) 157(20.7) Heart Disease
0.857 17(0.7) 5(0.7) Respiratory Disease
0.127 121(5.1) 50(6.6) Kindy Disease
<0.001 634(26.9) 359(47.2) Fever
0.953 499(21.2) 160(21.1) Odynophagia
<0.001 805(34.1) 384(50.5) Dry Cough
0.166 786(33.3) 274(36.1) Dyspnea
0.098 168(7.1) 41(5.4) Rhinorrhea
<0.001 494(20.9) 289(38.0) Chills
<0.001 199(8.4) 100(13.2) Vomiting
<0.001 321(13.6) 176(23.2) Nausea
0.021 256(10.9) 106(13.9) Diarrhea
<0.001 605(25.6) 280(36.8) Headache
<0.001 605(25.6) 308(40.5) Myalgia
<0.001 385(16.3) 218(28.7) Arthralgia
<0.001 558(23.7) 364(47.9) Anorexia
1.000 8(0.3) 2(0.3) Epistaxis**
<0.001 550(23.3) 311(40.9) Fatigue
0.378 20(0.8) 4(0.5) Convulsions
0.547 85(3.6) 31(4.1) Loss of consciousness
0.300 233(9.9) 85(11.2) Abdominal pain

*Positive RT-PCR test
** Fisher exact test report

 

Among 3945 suspected cases, 760 (24.4%) were RT-PCR positive with a mean age of 52.16 years and the median length of hospitalization of 8 days. The most frequent confirmed cases (41.9%) were in the age group of 36-59 years. 405 (53.3%) of the cases were male, 33 (4.3%) were medical staff, and 3 (0.4%) were pregnant women. Most of the cases were housewives (30.8), had HD (20.7%), and diabetes (17.6%). Among confirmed cases, the most common symptoms were dry cough (50.5%), anorexia (47.9%), and fever (47.2%); and the rare symptoms were epistaxis (0.3%), convulsions (0.5%), and loss of consciousness (4.1%). Out of the total confirmed cases, 63 patients (14.4%) died, with the highest frequency (88%) related to the age group of over 60 years. The symptoms such as fever, dry cough, chills, vomiting, nausea, diarrhea, headache, myalgia, arthralgia, anorexia, and fatigue were significantly higher in the confirmed cases than in the non-confirmed group, which highlights the importance of paying attention to the symptoms. The demographic and clinical characteristics of the suspected cases are shown in Table1.

Univariate analysis

Age, gender, diabetes, Heart Disease (HD), and obesity variables were included in the univariate logistic regression model (Table 2). The results suggested that the age over 60, diabetes, and obesity had an increasing effect on the odds of COVID-19.
The odds ratio of infection was approximately 1.5 times higher in people over 60 years, diabetic patients, and obese people.


Table2. Logistic regression for determining effective variables on COVID-19

Multivariate Univariate  
P-value OR(95% CI) P-value OR(95% CI)   Variables
<0.001 Ref <0.001 Ref <60 Age
1.84(1.48-2.29) 1.52(1.28-1.81) >=60
0.167 Ref 0.069 Ref female Sex
0.89(0.751.05) 0.86(0.73-1.01) male
0.007 Ref <0.001 Ref No Diabetes
1.40(1.08-1.77) 1.56(1.24-1.95) Yes
0.845 Ref 0.642 Ref No Heart Disease(HD)
1.04(0.72-1.50) 1.05(0.86-1.28) Yes
0.002 Ref <0.001 Ref No Obese
1.39(1.13-1.72) 1.44(1.17-1.76) Yes
0.011 0.55(0.35-0.87)       Age × HD


Multivariate analysis

Multivariate regression was run to determine the simultaneous effect of variables and some interactions (Table 2). The Hosmer-Lemeshow goodness of fit test confirmed the appropriateness of the model (p=0.411). The results were obtained as follows: The odds ratio of COVID-19 was 1.8 times higher for people over 60 (OR=1.84 , 95% CI 1.48-2.29) and 1.4 times higher for diabetics (OR=1.40, 95% CI 1.08-1.77) and obese people (OR=1.04, 95% CI 0.72-1.50). The odds ratio was significant for interaction of age and HD meaning that the odds ratio varied between different ages and HD (OR= 0.55, 95% CI 0.35-0.87) . Significant interaction showed that people over 60 years with HD reduce the risk.


 

Discussion

This study investigated the demographic characteristics of the COVID-19 suspected cases. The mean age of the confirmed cases was 52.16 years including an 18- day- old baby (14) to a person aged 98 years. This finding is consistent with the findings of a meta-analysis in China and Australia (15). A meta-analysis in the US reported that the mean age of confirmed cases was 60 years (16) and another meta-analysis reported the mean age of confirmed cases as 41 years (17). According to the results of different studies around the world, elderly people are more susceptible to the COVID-19 disease.
In this study, men and women were approximately equally affected by the disease, as was evident in a study in China (18).
The results of this study showed that confirmed cases had a higher BMI. There are a few articles on the effect of this variable on COVID-19 and their results showed obesity is more prevalent among confirmed cases (19-25).
In this study, 10% of the confirmed cases were medical staff, supporting the results of a study in China (18).
In our study, HD and diabetic individuals were more frequent among confirmed cases as indicated in other studies (19, 26-28). Besides, the frequency of diabetes was significantly higher in the confirmed cases. In a meta-analysis (15), 14.4% and 11.9% of the confirmed cases had CHD and diabetes, respectively and another meta-analysis (16) showed  that 38.9% of  the confirmed cases had diabetes.
Our findings showed that the most common COVID-19 symptoms were dry cough, anorexia, and fever as confirmed in other studies (15-17, 19, 29).
The results of multivariate logistic regression suggested that old age, diabetes and obesity increase, and old age concurrent with HD reduce the risk of developing COVID-19. These results may be justifiable because the elderly with HD receive greater care and thus are less likely to be affected. The findings from the meta-analysis showed being diabetic increases the risk of severe COVID-19 (30).


 

Conclusion

This study showed that patients with COVID-19 report dry cough in addition to anorexia and fever. These results necessitate further research on different symptoms in all countries. Clinicians should pay attention the indices of suspected cases including dry cough, fever and anorexia, old age, diabetes, and obesity to help identify COVID-19 cases on time and start treatment procedures earlier.
 
 

Acknowledgements

This work was supported by Shahroud University of Medical Sciences (Grant No. 98126) by the Ethics Council of Shahroud University of Medical Sciences (IR.SHMU.REC.1398.160).

 

Limitation:

The contradictory results may be due to sensitivity and specificity of RT-PCR test that categorizes true patients in non-confirmed cases.

 

Conflicts of Interest

The authors declare that there is no conflict of interest.

 

Type of Study: Original Article | Subject: Epidemiologic studies
Received: 2021/04/11 | Accepted: 2021/09/4 | Published: 2022/04/1

References
1. Organization WHO. World Health Organization coronavirus disease 2019 (COVID-19) situation report. 2020.
2. Emery SL, Erdman DD, Bowen MD,et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Disease. 2004;10(2):311. [DOI:10.3201/eid1002.030759] [PMID] [PMCID]
3. Team CC-R, Chow N, Fleming-Dutra K, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. Morbidity and Mortality Weekly Report. 2020;69(13):382-6. [DOI:10.15585/mmwr.mm6913e2] [PMID] [PMCID]
4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID]
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
6. Jiang W, Zeng Z, Fan D, et al. Decreased counts of T lymphocyte subsets predict prognosis in SARS-CoV-2-infected pneumonia in Wuhan, China: A retrospective study. (February 20, 2020). 2020. [DOI:10.2139/ssrn.3542361]
7. Wu P, Hao X, Lau EH, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance. 2020;25(3):2000044. [DOI:10.2807/1560-7917.ES.2020.25.3.2000044] [PMID] [PMCID]
8. Farnoosh G, Alishiri G, Zijoud S, Dorostkar R, Farahani AJ. Understanding the 2019-novel coronavirus (2019-nCoV) and coronavirus disease (COVID-19) based on available evidence-a narrative review. J Mil Med. 2020;22(1):1-11.
9. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
10. Sun P, Qie S, Liu Z, Ren J, Xi JJ. Clinical characteristics of 50466 patients with 2019-nCoV infection. medRxiv. 2020. [DOI:10.1101/2020.02.18.20024539]
11. Jiehao C, Jin X, Daojiong L, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Disease. 2020;71(6):1547-51. [DOI:10.1093/cid/ciaa198] [PMID] [PMCID]
12. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. [DOI:10.1001/jama.2020.6775] [PMID] [PMCID]
13. Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The lancet. 2020;395(10223):514-23. [DOI:10.1016/S0140-6736(20)30154-9]
14. Mahdavi S, Kheirieh A, Daliri S, et al. More reliability of suspicious symptoms plus chest CT-scan than RT_PCR test for the diagnosis of COVID-19 in an 18-days-old neonate. IDCases. 2020;21:e00905. [DOI:10.1016/j.idcr.2020.e00905] [PMID] [PMCID]
15. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Disease. 2020;34:101623. [DOI:10.1016/j.tmaid.2020.101623] [PMID] [PMCID]
16. Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA. 2020;180(11):1436-46.
17. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656-65. [DOI:10.1016/j.jinf.2020.03.041] [PMID] [PMCID]
18. Qian J, Zhao L, Ye RZ. Age-dependent gender differences in COVID-19 in Mainland China: Comparative study. Clin Infect Disease. 2020;71(9):2488-94. [DOI:10.1093/cid/ciaa683] [PMID] [PMCID]
19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62. [DOI:10.1016/S0140-6736(20)30566-3]
20. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region-case series. New Eng J Med. 2020;382(21):2012-22. [DOI:10.1056/NEJMoa2004500] [PMID] [PMCID]
21. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-6. [DOI:10.1001/jama.2020.4031] [PMID]
22. Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Disease. 2020;71(15):896-7. [DOI:10.1093/cid/ciaa415] [PMID] [PMCID]
23. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195-9. [DOI:10.1002/oby.22831] [PMID] [PMCID]
24. Gao F, Zheng KI, Wang XB, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020;43(7):e72-e4. [DOI:10.2337/dc20-0682] [PMID]
25. Goldberg SA, Pu CT, Thompson RW, Mark E, Sequist TD, Grabowski DC. Asymptomatic spread of COVID-19 in 97 patients at a skilled nursing facility. J Am Med Direct Assoc. 2020;21(7):980-1. [DOI:10.1016/j.jamda.2020.05.040] [PMID] [PMCID]
26. Pung R, Chiew CJ, Young BE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. The Lancet. 2020;395(10229):1039-46. [DOI:10.1016/S0140-6736(20)30528-6]
27. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
28. Zhao X, Zhang B, Li P, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020.
29. Gupta N, Agrawal S, Ish P, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Disease. 2020;90(1). [DOI:10.4081/monaldi.2020.1294]
30. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia-a systematic review, meta-analysis, and meta-regression. Diabetes & Metabolic Syndrome: Clin Res & Rev. 2020;14(4):395-403. [DOI:10.1016/j.dsx.2020.04.018] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb